WDB coco Co., Ltd. logo

WDB coco Co., Ltd.

7079.T

JPXIndustrialsSpecialty Business Services

Latest quote

¥2,583

+¥1.00 · +0.04%

Aug 24, 9:00 AM JSTData delayed

7079.T company overview

Company profile

Company website

WDB coco Co., Ltd. offers specialized contractual services to pharmaceutical companies throughout Japan. The firm plays a crucial role in advancing pharmaceuticals and medical devices, with a particular focus on safety information management, support for safety data systems, clinical research assistance, and post-market safety operations. Its offerings also encompass translation and quality control document preparation, additional clinical study support, and personnel dispatch. Furthermore, WDB coco provides comprehensive post-marketing surveillance (PMS) solutions, which include securing agreements with healthcare facilities, explaining survey protocols, collecting survey forms, conducting detailed monitoring (like re-surveys), managing a central case registration center, handling data, and performing statistical analyses. Established in 1984, the company's headquarters are located in Tokyo, Japan.

Industry
Specialty Business Services
Sector
Industrials
Headquarters
JP
CEO
Haruhiko Taniguchi
Listed since
Dec 26, 2019
Employees
516

Market position

Volume
100
0.07× average
Average volume
1.51K
Average daily volume
Market cap
6.21B JPY
Beta
0.2
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.56B JPY
P/E (TTM)
0.95×
P/B (TTM)
0.03×
P/S (TTM)
0.11×
EV / EBITDA
2.52×
Earnings yield
10.89%
Free cash flow yield
8.36%
Dividend yield
3.68%

Profitability & efficiency

Gross margin
33.86%
Operating margin
17.54%
Net margin
12.11%
Return on equity
14.20%
Return on assets
11.91%
Return on invested capital
13.24%

Financial health

Debt / equity
0.01×
Current ratio
7.8×

Earnings

Latest EPS result
57.27

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates110.5888.265.8343.45Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 8, 2024: actual 91.05, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 7, 2025: actual 82.53, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 105.95, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual 67.98, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 7, 2025: actual 48.08, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 6, 2026: actual 74.16, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual 92.25, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 7, 2026: actual 57.27, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.44B1.33B1.21B1.1BQ4 '24BeatQ1 '25BeatQ2 '25BeatQ3 '25No estimateQ4 '25No estimateQ1 '26No estimateQ2 '26No estimateQ3 '26No estimate
Q4 2024, reported Nov 8, 2024: actual 1.32B JPY, estimate 1.26B JPY, surprise +4.37%, Beat. Q1 2025, reported Feb 7, 2025: actual 1.39B JPY, estimate 1.29B JPY, surprise +7.52%, Beat. Q2 2025, reported May 14, 2025: actual 1.34B JPY, estimate 1.32B JPY, surprise +1.74%, Beat. Q3 2025, reported Aug 8, 2025: actual 1.26B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 7, 2025: actual 1.16B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 6, 2026: actual 1.22B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual 1.18B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 7, 2026: actual 1.15B JPY, estimate —, surprise —, Comparison unavailable.

7079.T peers

Continue in GoAI

Research 7079.T

research.disclaimer